93 related articles for article (PubMed ID: 9352356)
1. Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents.
Cahalon L; Lider O; Schor H; Avron A; Gilat D; Hershkoviz R; Margalit R; Eshel A; Shoseyev O; Cohen IR
Int Immunol; 1997 Oct; 9(10):1517-22. PubMed ID: 9352356
[TBL] [Abstract][Full Text] [Related]
2. A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.
Lider O; Cahalon L; Gilat D; Hershkoviz R; Siegel D; Margalit R; Shoseyov O; Cohen IR
Proc Natl Acad Sci U S A; 1995 May; 92(11):5037-41. PubMed ID: 7761444
[TBL] [Abstract][Full Text] [Related]
3. Cu/Zn superoxide dismutase plays important role in immune response.
Marikovsky M; Ziv V; Nevo N; Harris-Cerruti C; Mahler O
J Immunol; 2003 Mar; 170(6):2993-3001. PubMed ID: 12626552
[TBL] [Abstract][Full Text] [Related]
4. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration.
Rolls A; Cahalon L; Bakalash S; Avidan H; Lider O; Schwartz M
FASEB J; 2006 Mar; 20(3):547-9. PubMed ID: 16396993
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
[TBL] [Abstract][Full Text] [Related]
6. Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling.
Hecht I; Hershkoviz R; Shivtiel S; Lapidot T; Cohen IR; Lider O; Cahalon L
J Leukoc Biol; 2004 Jun; 75(6):1139-46. PubMed ID: 15020655
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and immunosuppressive activities of 1,3-dicyclopentyl-1,2,3,6-tetrahydropyrimidine-4,5-dicarboxylic acid diethyl ester (ZL-5015).
Lun Y; Xia H; Zhang Q; Yu C; Chen N; Li X; Liu S; Lei L
Int Immunopharmacol; 2013 Oct; 17(2):168-77. PubMed ID: 23791971
[TBL] [Abstract][Full Text] [Related]
8. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.
Cicala C; Ianaro A; Fiorucci S; Calignano A; Bucci M; Gerli R; Santucci L; Wallace JL; Cirino G
Br J Pharmacol; 2000 Jul; 130(6):1399-405. PubMed ID: 10903982
[TBL] [Abstract][Full Text] [Related]
9. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis.
Saso Y; Conner EM; Teegarden BR; Yuan CS
J Pharmacol Exp Ther; 2001 Jan; 296(1):106-12. PubMed ID: 11123369
[TBL] [Abstract][Full Text] [Related]
10. [Effects of leflunomide and its active metabolite on the production and mRNA expression of TNF-alpha in peritoneal macrophages and synovial cells with adjuvant arthritis in rats].
Li WD; Lin ZB
Yao Xue Xue Bao; 2002 Oct; 37(10):767-70. PubMed ID: 12567858
[TBL] [Abstract][Full Text] [Related]
11. The leaf extract of Spondias mombin L. displays an anti-inflammatory effect and suppresses inducible formation of tumor necrosis factor-α and nitric oxide (NO).
Nworu CS; Akah PA; Okoye FB; Toukam DK; Udeh J; Esimone CO
J Immunotoxicol; 2011; 8(1):10-6. PubMed ID: 21261441
[TBL] [Abstract][Full Text] [Related]
12. Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling.
Babazada H; Yamashita F; Yanamoto S; Hashida M
J Control Release; 2014 Nov; 194():332-40. PubMed ID: 25234820
[TBL] [Abstract][Full Text] [Related]
13. Antiinflammatory properties of a peptide derived from interleukin-4.
Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and immunosuppressive effects of 1,6-anhydro-3,4-dideoxy-2-furfuryl-beta-D-threo-3-enopyranose (MT2221), a novel anhydro-enopyranose derivative, on experimental animal models.
Mizukoshi S; Tsukamoto M; Tanaka H; Nakamura K; Kato F
Biol Pharm Bull; 1994 Aug; 17(8):1070-4. PubMed ID: 7820110
[TBL] [Abstract][Full Text] [Related]
15. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.
Lider O; Baharav E; Mekori YA; Miller T; Naparstek Y; Vlodavsky I; Cohen IR
J Clin Invest; 1989 Mar; 83(3):752-6. PubMed ID: 2493485
[TBL] [Abstract][Full Text] [Related]
17. 7-hydroxyfrullanolide, a sesquiterpene lactone, inhibits pro-inflammatory cytokine production from immune cells and is orally efficacious in animal models of inflammation.
Fonseca LC; Dadarkar SS; Lobo AS; Suthar AC; Chauhan VS; Chandrababu S; Sharma SD; Dagia NM; Padigaru M
Eur J Pharmacol; 2010 Oct; 644(1-3):220-9. PubMed ID: 20621086
[TBL] [Abstract][Full Text] [Related]
18. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism.
Salas A; Sans M; Soriano A; Reverter JC; Anderson DC; Piqué JM; Panés J
Gut; 2000 Jul; 47(1):88-96. PubMed ID: 10861269
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-κB signaling.
Babazada H; Yamashita F; Hashida M
J Control Release; 2014 Nov; 194():295-300. PubMed ID: 25242730
[TBL] [Abstract][Full Text] [Related]
20. SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo.
Murai M; Tsuji F; Nose M; Seki I; Oki K; Setoguchi C; Suhara H; Sasano M; Aono H
Eur J Pharmacol; 2008 Jul; 588(2-3):309-15. PubMed ID: 18508045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
